Provided by Tiger Trade Technology Pte. Ltd.

ARS PHARMACEUTICALS INC

5.87
-0.1350-2.25%
Volume:760.08K
Turnover:4.52M
Market Cap:583.26M
PE:-2.70
High:6.07
Open:5.93
Low:5.83
Close:6.00
52wk High:13.15
52wk Low:4.91
Shares:99.45M
Float Shares:48.03M
Volume Ratio:0.62
T/O Rate:1.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1757
EPS(LYR):-1.7400
ROE:-210.35%
ROA:-48.02%
PB:46.62
PE(LYR):-3.37

Loading ...

Sep 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2024

Major Issues Report

Form 8-K - Current report
Aug 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2024

Major Issues Report

Form 8-K - Current report
Jul 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 28, 2024

Major Issues Report

Form 8-K - Current report
Jun 28, 2024

Major Issues Report

Form 8-K - Current report
Jun 21, 2024

Major Issues Report

Form 8-K - Current report
Jun 17, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 11, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 10, 2024

Major Issues Report

Form 8-K - Current report
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2024

Major Issues Report

Form 8-K - Current report
Mar 29, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]